The heightened expression of CD-44 in cancer cell lines, including MCF-7, MDA-MB-468, and MDA-MB-23152, along with its strong affinity for hyaluronic acid (HA), has garnered significant attention in the context of breast cancer treatment. This evidence concerns the gene CD44 and cancer.